Especialidades

¡Oferta!

BNF 81

¡Oferta!

81,06 77,00

Autor: Joint Formulary Committee
Editor: BMJ / Royal Pharmaceutical Society
Edición: 81 March 2021
Año edición: 2021
SKU: 9780857114105 Categoría:
Extensive content updates in the BNF 81 edition include:
New monographs for:
  • Fetcroja ® [cefiderocol] for aerobic Gram-negative infections in patients with limited treatment options
  • Jyseleca ® [filgotinib] for rheumatoid arthritis
  • Myopridin® [pridinol] for central and peripheral muscle spasms
  • Nilemdo® [bempedoic acid] for primary hypercholesterolaemia or mixed dyslipidaemia in patients who have not responded adequately to other appropriate measures
  • Sunosi® [solriamfetol] for excessive sleepiness associated with narcolepsy
  • Veklury® [remdesivir] for COVID-19 in patients with pneumonia requiring supplemental oxygen
  • Zeposia® [ozanimod] for multiple sclerosis

New preparations:

  • Rybelsus ® [semaglutide]: oral formulation for type 2 diabetes
  • Spravato ® [esketamine]: intranasal spray for major depressive disorder
MHRA advice on:
  • Clozapine and other antipsychotics: monitoring blood concentrations for toxicity
  • Direct-acting oral anticoagulants (DOACs): reminder of bleeding risk, availability of reversal agents
  • Stimulant laxatives available over-the-counter: new measures to support their safe use
  • Cyproterone acetate: new advice and restrictions of use to minimise risk of meningioma
  • Insulins (all types): risk of cutaneous amyloidosis at injection site
  • Methotrexate once-weekly for autoimmune diseases: new measures to reduce risk of fatal overdose due to inadvertent daily instead of weekly dosing
  • Morphine and other opioids: new guidance to risk of dependence and addiction

 

CONTENTS : 

Preface page
Acknowledgements
How BNF publications are constructed
How to use BNF Publications in print
Changes
Guidance on Prescribing
Prescription writing
Emergency supply of medicines
Controlled drugs and drug dependence
Adverse reactions to drugs
Guidance on intravenous infusions
Medicines optimisation
Antimicrobial stewardship
Prescribing for children
Prescribing in hepatic impairment
Prescribing in renal impairment
Prescribing in pregnancy
Prescribing in breast-feeding
Prescribing in palliative care
Prescribing for the elderly
Drugs and sport
Prescribing in dental practice
NOTES ON DRUGS AND PREPARATIONS
1 Gastro-intestinal system page
2 Cardiovascular system
3 Respiratory system
4 Nervous system
5 Infection
6 Endocrine system
7 Genito-urinary system
8 Immune system and malignant disease
9 Blood and nutrition
10 Musculoskeletal system
11 Eye
12 Ear, nose and oropharynx
13 Skin
14 Vaccines
15 Anaesthesia
16 Emergency treatment of poisoning
APPENDICES AND INDICES
Appendix 1 – Interactions
Appendix 2 – Borderline substances
Appendix 3 – Cautionary and advisory labels for dispensed medicines
Appendix 4 – Wound management products and elasticated garments
Dental Practitioners’ Formulary
Nurse Prescribers’ Formulary
Non-medical prescribing
Index of manufacturers
Special-order Manufacturers
Index

Valoraciones

No hay valoraciones aún.

Sé el primero en valorar “BNF 81”

Tu dirección de correo electrónico no será publicada. Los campos obligatorios están marcados con *

Ir arriba